Christopher Peetz's most recent trade in Mirum Pharmaceuticals Inc was a trade of 40,000 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 11 Aug 2025 | 40,000 | 178,641 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 40,000 | 158,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 11 Aug 2025 | 40,000 | 138,641 (0%) | 0% | 62 | 2,480,000 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.25 per share. | 07 Aug 2025 | 40,000 | 138,641 (0%) | 0% | 55.3 | 2,210,040 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 07 Aug 2025 | 40,000 | 178,641 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 40,000 | 198,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 25,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 165,920 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.21 per share. | 15 Mar 2025 | 27,279 | 138,641 (0%) | 0% | 44.2 | 1,206,122 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 03 Mar 2025 | 40,000 | 155,920 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 40,000 | 238,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.19 per share. | 03 Mar 2025 | 20,608 | 115,920 (0%) | 0% | 47.2 | 972,492 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.61 per share. | 03 Mar 2025 | 19,392 | 136,528 (0%) | 0% | 46.6 | 903,861 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.22 per share. | 03 Feb 2025 | 9,102 | 115,920 (0%) | 0% | 48.2 | 438,921 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 131,859 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 23 Jan 2025 | 6,837 | 125,022 (0%) | 0% | 47.9 | 327,658 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 153,550 | 153,550 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 75,000 | 75,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 38,390 | 38,390 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 07 Jan 2025 | 7,489 | 119,359 (0%) | 0% | 42.8 | 320,644 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 08 Nov 2024 | 65 | 126,848 (0%) | 0% | 21.0 | 1,368 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 34,013 | 278,487 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 23 Jul 2024 | 34,013 | 126,783 (0%) | 0% | 2.9 | 99,862 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 1,900 | 0 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 10 May 2024 | 817 | 92,770 (0%) | 0% | 21.0 | 17,195 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 02 Feb 2024 | 6,013 | 104,112 (0%) | 0% | 26.2 | 157,491 | Common Stock |
| Mirum Pharmaceuticals Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 08 Jan 2024 | 5,209 | 110,125 (0%) | 0% | 28.0 | 146,033 | Common Stock |
| Alpine Immune Sciences Inc | Peetz Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.65 per share. | 03 Jul 2023 | 5,498 | 115,334 (0%) | 0% | 25.6 | 141,005 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 16.92 per share. | 10 May 2023 | 1,256 | 120,832 (0%) | 0% | 16.9 | 21,256 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 50,000 | 119,576 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 09 Jan 2023 | 5,159 | 91,953 (0%) | 0% | 20.6 | 106,390 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 17.04 per share. | 10 Nov 2022 | 49 | 69,576 (0%) | 0% | 17.0 | 835 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 13.57 per share. | 10 May 2022 | 1,500 | 69,527 (0%) | 0% | 13.6 | 20,349 | Common STock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 40,000 | 68,027 (0%) | 0% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 14.40 per share. | 24 Nov 2021 | 7,000 | 28,027 (0%) | 0% | 14.4 | 100,800 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Purchase of securities on an exchange or from another person at price $ 10.17 per share. | 23 Sep 2021 | 1,900 | 1,900 (0%) | 0% | 10.2 | 19,323 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 14.62 per share. | 10 May 2021 | 1,453 | 2,824 (0%) | 0% | 14.6 | 21,243 | Common STock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,650 | 7,650 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.76 per share. | 23 Dec 2020 | 3,000 | 199,570 (0%) | 0% | 18.8 | 56,280 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.60 per share. | 23 Dec 2020 | 2,000 | 201,570 (0%) | 0% | 18.6 | 37,200 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 15.27 per share. | 10 Nov 2020 | 1,371 | 1,371 (0%) | 0% | 15.3 | 20,930 | Common STock |